About Us
The company's European Research and Development headquarters – and Europe's largest biomedical research facility – Sandwich has been at the forefront of groundbreaking pharmaceutical innovation for over half a century.
Our dedication and ingenuity has led to the discovery of some of the world's best-selling medicines.
At this very moment, more than 2,500 R&D scientists at Sandwich are busy developing over 200 projects across the therapeutic areas of Pain, Allergy & Respiratory, Infectious Diseases (antivirals), Genitourinary, Gastrointestinal and Hepatology. As a result of which millions of people around the world will enjoy healthier, happier lives for years to come.
